1. Clinical Overview
A fixed-dose combination (FDC) of an ACE inhibitor (Ramipril) and an HMG-CoA reductase inhibitor (Atorvastatin). It is primarily indicated for the management of hypertension and dyslipidemia in patients with concomitant cardiovascular risk factors, particularly for secondary prevention in post-myocardial infarction and post-stroke patients. This combination addresses two major modifiable risk factors for atherosclerotic cardiovascular disease (ASCVD).
| Onset | Duration | Bioavailability |
|---|---|---|
| Ramipril: Antihypertensive effect begins within 1-2 hours, with peak effect at 3-6 hours. Atorvastatin: LDL-C reduction begins within 2 weeks, maximal effect at 4 weeks. | Ramipril: Sustained 24-hour antihypertensive effect with once-daily dosing. Atorvastatin: Requires daily dosing; effect persists for the dosing interval. | Ramipril: Approximately 50-60%. Atorvastatin: ~14% due to extensive first-pass metabolism. |
2. Mechanism of Action
Ramipril inhibits Angiotensin Converting Enzyme (ACE), preventing conversion of Angiotensin I to Angiotensin II (a potent vasoconstrictor), leading to vasodilation, reduced aldosterone secretion (decreasing sodium/water retention), and increased bradykinin levels. Atorvastatin competitively inhibits HMG-CoA reductase, the rate-limiting enzyme in the mevalonate pathway, thereby depleting intracellular cholesterol pools and upregulating hepatic LDL receptors, increasing clearance of LDL-cholesterol from the bloodstream.
3. Indications & Uses
- Hypertension (with concomitant dyslipidemia)
- Secondary prevention of cardiovascular events (e.g., post-MI, post-stroke, revascularization) in patients with dyslipidemia
- Primary prevention in diabetic patients with hypertension and dyslipidemia and other risk factors
4. Dosage & Administration
Adult Dosage: One tablet (Ramipril 5mg + Atorvastatin 10mg) once daily. Dose should be individualized based on BP and lipid response. Can be taken at any time of day, with or without food (consistent timing recommended).
Administration: Swallow whole with a glass of water. Can be taken with or without food, but taking Atorvastatin in the evening may provide slightly greater LDL-C reduction. Do not crush or chew. Missed dose: Take as soon as remembered, but if it's almost time for next dose, skip the missed dose. Do not double dose.
5. Side Effects
Common side effects may include:
- Headache
- Dizziness
- Fatigue
- Cough (dry, persistent, tickling - due to Ramipril)
- Nausea, constipation, dyspepsia
- Myalgia (muscle pain) - due to Atorvastatin
- Increased liver enzymes (AST/ALT)
6. Drug Interactions
| Drug | Effect | Severity |
|---|---|---|
| Diuretics (especially loop/thiazide) | Potentiates hypotensive effect; risk of first-dose hypotension. | Major |
| Potassium-sparing diuretics (Spironolactone, Amiloride), Potassium supplements | Increased risk of hyperkalemia. | Major |
| NSAIDs (e.g., Ibuprofen, Diclofenac) | May diminish antihypertensive effect of Ramipril and increase risk of renal impairment. | Major |
| Lithium | Ramipril may increase serum Lithium levels and toxicity. | Major |
| Aliskiren | Increased risk of renal impairment, hyperkalemia, and hypotension in diabetics or renally impaired. | Contraindicated in specific populations |
| Potent CYP3A4 Inhibitors (Itraconazole, Clarithromycin, HIV protease inhibitors, Cyclosporine, Gemfibrozil) | Significantly increases Atorvastatin plasma levels, raising risk of myopathy/rhabdomyolysis. | Major / Contraindicated with some |
| Warfarin | Atorvastatin may potentiate anticoagulant effect; monitor INR closely. | Moderate |
| Oral Contraceptives | Atorvastatin may increase levels of Norethindrone and Ethinyl Estradiol. | Moderate |
| Colchicine | Increased risk of myopathy, especially in renal impairment. | Major |
| Antacids | May decrease bioavailability of Atorvastatin; separate administration by at least 2 hours. | Minor |
7. Patient Counselling
- Do take the medicine at the same time each day for best results.
- Do continue taking this medicine even if you feel well. Hypertension and high cholesterol often have no symptoms.
- Do get your blood pressure, kidney function (creatinine), potassium, and liver function (ALT) checked regularly as advised by your doctor.
- Do report any unexplained muscle pain, tenderness, weakness, or dark-colored urine immediately.
- Don't stop taking this medicine without consulting your doctor, as conditions may worsen.
- Don't take this medicine if you are pregnant, planning pregnancy, or breastfeeding.
- Don't consume grapefruit or grapefruit juice while on this medication.
- Don't take over-the-counter NSAIDs (like ibuprofen) for pain/fever without consulting your doctor.
8. Toxicology & Storage
Overdose: Ramipril: Profound hypotension, circulatory shock, bradycardia, electrolyte disturbances (hyperkalemia, hyponatremia), acute renal failure. Atorvastatin: Elevated liver enzymes, possible severe myopathy/rhabdomyolysis with acute renal failure.
Storage: Store below 30°C. Protect from light and moisture. Keep in the original blister pack or container. Keep out of reach and sight of children. Do not use after the expiry date printed on the pack.